Discontinued — last reported Q1 '26
Pharmaceutical — Cost of Sales
Merck & Co. Pharmaceutical — Cost of Sales decreased by 15.6% to $1.55B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 1.3%, from $1.57B to $1.55B. Over 3 years (FY 2022 to FY 2025), Pharmaceutical — Cost of Sales shows a downward trend with a -11.6% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Analysis
How to read this metric
A lower ratio relative to sales indicates improved manufacturing efficiency or favorable product mix.
Detailed definition
The direct costs associated with producing and distributing pharmaceutical products, including raw materials, manufactur...
Peer comparison
Typically ranges between 20-35% of sales for major pharmaceutical firms depending on the complexity of the drug portfolio.
mrk_segment_pharmaceutical_segment_cost_of_salesHistorical Data
| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.42B | $2.42B | $2.42B | $2.42B | $2.21B | $2.21B | $2.21B | $2.21B | $1.71B | $1.71B | $1.90B | $1.51B | $1.57B | $1.60B | $1.66B | $1.84B | $1.55B |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | -8.6% | +0.0% | +0.0% | +0.0% | -22.9% | +0.1% | +11.5% | -20.7% | +4.2% | +1.8% | +3.9% | +10.6% | -15.6% |
| YoY Change | — | — | — | — | -8.6% | -8.6% | -8.6% | -8.6% | -22.9% | -22.8% | -13.9% | -31.7% | -7.8% | -6.3% | -12.6% | +21.9% | -1.3% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Merck & Co.'s pharmaceutical — cost of sales?
- Merck & Co. (MRK) reported pharmaceutical — cost of sales of $1.55B in Q1 2026.
- How has Merck & Co.'s pharmaceutical — cost of sales changed year-over-year?
- Merck & Co.'s pharmaceutical — cost of sales decreased by 1.3% year-over-year, from $1.57B to $1.55B.
- What is the long-term trend for Merck & Co.'s pharmaceutical — cost of sales?
- Over 3 years (2022 to 2025), Merck & Co.'s pharmaceutical — cost of sales has grown at a -11.6% compound annual growth rate (CAGR), from $9.68B to $6.68B.
- What does pharmaceutical — cost of sales mean?
- The direct costs incurred to manufacture and deliver pharmaceutical products to customers.